Persistent efficacy of tumor necrosis factor alpha blockage therapy in SAPHO syndrome : comment on the article by Wagner et al
| Errataetall: |
CommentOn: Arthritis Rheum. 2002 Jul;46(7):1965-8. - PMID 12124882 |
|---|---|
| Medienart: |
Artikel |
| Erscheinungsjahr: |
2003 |
|---|---|
| Erschienen: |
2003 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:48 |
|---|---|
| Enthalten in: |
Arthritis and rheumatism - 48(2003), 5 vom: 01. Mai, Seite 1467; author reply 1467-8 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Olivieri, Ignazio [VerfasserIn] |
|---|
| Themen: |
Antibodies, Monoclonal |
|---|
| Anmerkungen: |
Date Completed 30.05.2003 Date Revised 19.11.2015 published: Print CommentOn: Arthritis Rheum. 2002 Jul;46(7):1965-8. - PMID 12124882 Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM125150830 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM125150830 | ||
| 003 | DE-627 | ||
| 005 | 20231222205110.0 | ||
| 007 | tu | ||
| 008 | 231222s2003 xx ||||| 00| ||eng c | ||
| 028 | 5 | 2 | |a pubmed24n0417.xml |
| 035 | |a (DE-627)NLM125150830 | ||
| 035 | |a (NLM)12746931 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Olivieri, Ignazio |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Persistent efficacy of tumor necrosis factor alpha blockage therapy in SAPHO syndrome |b comment on the article by Wagner et al |
| 264 | 1 | |c 2003 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 30.05.2003 | ||
| 500 | |a Date Revised 19.11.2015 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentOn: Arthritis Rheum. 2002 Jul;46(7):1965-8. - PMID 12124882 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Comment | |
| 650 | 4 | |a Letter | |
| 650 | 7 | |a Antibodies, Monoclonal |2 NLM | |
| 650 | 7 | |a Receptors, Tumor Necrosis Factor |2 NLM | |
| 650 | 7 | |a Infliximab |2 NLM | |
| 650 | 7 | |a B72HH48FLU |2 NLM | |
| 700 | 1 | |a Padula, Angela |e verfasserin |4 aut | |
| 700 | 1 | |a Ciancìo, Giovanni |e verfasserin |4 aut | |
| 700 | 1 | |a Salvarani, Carlo |e verfasserin |4 aut | |
| 700 | 1 | |a Niccoli, Laura |e verfasserin |4 aut | |
| 700 | 1 | |a Cantini, Fabrizio |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Arthritis and rheumatism |d 1958 |g 48(2003), 5 vom: 01. Mai, Seite 1467; author reply 1467-8 |w (DE-627)NLM000079391 |x 1529-0131 |7 nnns |
| 773 | 1 | 8 | |g volume:48 |g year:2003 |g number:5 |g day:01 |g month:05 |g pages:1467; author reply 1467-8 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 48 |j 2003 |e 5 |b 01 |c 05 |h 1467; author reply 1467-8 | ||